SCHEMBL15218385

SCHEMBL15218385

Cc1ccc(-c2cc3nccc(C(C)(C)C)c3s2)cn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 2/20 0.38
PIK3CD O00329 1/20 0.38
PIK3CB P42338 1/20 0.38
PI4KA P42356 1/20 0.38
PIK3CG P48736 1/20 0.38
PI4KB Q9UBF8 1/20 0.38
NPC1 O15118 3/20 0.36
RAB9A P51151 3/20 0.36
KMT2A Q03164 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
HPGDS O60760 1/20 0.35
TYK2 P29597 1/20 0.35
KIT P10721 1/20 0.34
CHEK1 O14757 1/20 0.33
MAP3K8 P41279 2/20 0.33
STK17B O94768 1/20 0.33
PDPK1 O15530 2/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15218383 0.86 MAP3K8 (0.44) NPC1RAB9AKMT2ATDP1TYK2
SCHEMBL10224583 0.80 NPC1 (0.41) PIK3CAPIK3CDPIK3CBPI4KAPIK3CG
SCHEMBL12806955 0.76 GRIN3B (0.35) KITPDPK1GRIN2DGRIN3BGRIN1
SCHEMBL15218381 0.74 MET (0.39) KDM4EALDH1A1TSHRHSD17B10GRIN3B
SCHEMBL2602165 0.72 PDPK1 (0.49) KMT2APDPK1KDM4EALDH1A1SMN1; SMN2
SCHEMBL15218384 0.71 MET (0.42)
SCHEMBL15889701 0.71 MET (0.46)
SCHEMBL26661978 0.70
SCHEMBL12734111 0.69 GRIN3B (0.36) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL2605679 0.69 GRIN3B (0.36) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130225581-A1 NITROGEN-CONTAINING AROMATIC HETEROCYCLIC DERIVATIVE KYOWA HAKKO KIRIN CO., LTD (JP) 2013-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130225581-A1 NITROGEN-CONTAINING AROMATIC HETEROCYCLIC DERIVATIVE FGFR3, FGFR1, FGFR4 PIK3CA 353/4885PIK3CD 630/4885PIK3CB 900/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.